Frontiers in Pharmacology | Neuropharmacology

Systematic Review

Published on 23 Oct 2024

Stem cell-derived exosomes for ischemic stroke: a conventional and network meta-analysis based on animal models

in Neuropharmacology

Kangli Xu
Xiaohui Zhao
Yuxuan He
Hongxin Guo
Yunke Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1481617

3,427 views
1 citation

Original Research

Published on 22 Oct 2024

Green rush and red warnings: Retrospective chart review of adverse events of interactions between cannabinoids and psychotropic drugs

in Neuropharmacology

Adrian Andrzej Chrobak
Jarosław Woroń
Marcin Siwek

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1500312

2,368 views
1 citation

Original Research

Published on 17 Oct 2024

Precuneal hyperperfusion in patients with attention-deficit/hyperactivity disorder-comorbid nociplastic pain

in Neuropharmacology

Miwako Takahashi
Satoshi Kasahara
Tsutomu Soma
Taito Morita
Naoko Sato
Ko Matsudaira
Shin-Ichi Niwa
Toshimitsu Momose

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1480546

2,915 views
1 citation

Review

Published on 17 Oct 2024

The role of exercise-related FNDC5/irisin in depression

in Neuropharmacology

Yaqi Liu
Xiying Fu
Xing Zhao
Ranji Cui
Wei Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1461995

2,478 views
4 citations

Systematic Review

Published on 17 Oct 2024

The effects of standardized cannabis products in healthy volunteers and patients: a systematic literature review

in Neuropharmacology

Nadia A. Leen
Mikael A. Kowal
Albert Batalla
Matthijs G. Bossong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1411631

2,791 views

Original Research

Published on 16 Oct 2024

Decreasing brain activity caused by acute administration of ketamine and alcohol – A randomized, controlled, observer-blinded experimental study

in Neuropharmacology

Luan Oliveira Ferreira
Esther Padilha da Silveira
Clarissa A. Paz
Maria K. Otake Hamoy
Gabriela B. Barbosa
Murilo F. Santos
Raína M. Conceição
Anthony Lucas G. Amaral
Karina Dias Resende
Dielly Catrina Favacho Lopes

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1456009

969 views

Editorial

Published on 14 Oct 2024

Editorial: New players on the monoaminergic field: relevance to the mental disorders

in Neuropharmacology

Eliyahu Dremencov
Daniela Jezova

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1504261

700 views

Original Research

Published on 14 Oct 2024

Identification and experimental validation of hub genes underlying depressive-like behaviors induced by chronic social defeat stress

in Neuropharmacology

Yexiang Chen
Yunhao Jiang
Xingcong Jiang
Caiyu Zhai
Yifei Wang
Chi Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1472468

1,152 views

Brief Research Report

Published on 10 Oct 2024

Chronic exposure to inhaled vaporized cannabis high in Δ9-THC suppresses Adderall-induced brain activity

in Neuropharmacology

Jack M. Ognibene
Rajeev I. Desai
Praveen P. Kulkarni
Craig F. Ferris

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413812

4,307 views

Original Research

Published on 09 Oct 2024

Fentanyl enhances immune cell response through TLR4/MD-2 complex

in Neuropharmacology

Chiara Chemello
Laura Facci
Emma Marcolin
Giovanni Eugenio Ramaschi
Massimo Barbierato
Pietro Giusti
Chiara Bolego
Morena Zusso

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1468644

1,527 views

Original Research

Published on 07 Oct 2024

Inhibition of HCN1 currents by norquetiapine, an active metabolite of the atypical anti-psychotic drug quetiapine

in Neuropharmacology

Amélie Jean Jacques
Nazzareno D’Avanzo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1445509

1,203 views

Editorial

Published on 03 Oct 2024

Editorial: Reviews in neuropharmacology 2023: microbiota gut-brain axis, therapeutic insights for neurodegenerative diseases

in Neuropharmacology

Bhagavathi Sundaram Sivamaruthi
Natarajan Suganthy
Carolina Pellegrini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1499072

851 views

Mini Review

Published on 02 Oct 2024

Autophagy is a promising process for linking inflammation and redox homeostasis in Down syndrome

in Neuropharmacology

Xuehai Ma
Weimin Li
Jun Ma
Zhongcheng Han
Shoulong Deng
Sutian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491563

993 views
1 citation

Brief Research Report

Published on 02 Oct 2024

Isoflurane-lipid emulsion injection as an anticonvulsant and neuroprotectant treatment for nerve agent exposure

in Neuropharmacology

Jishnu K. S. Krishnan
John R. Moffett
Narayanan Puthillathu
Erik A. Johnson
Aryan M. Namboodiri

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1466351

826 views

Review

Published on 02 Oct 2024

Single-cell profiling of cellular changes in the somatic peripheral nerves following nerve injury

in Neuropharmacology

Li Zhao
Chunyi Jiang
Bin Yu
Jianwei Zhu
Yuyu Sun
Sheng Yi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448253

1,600 views
1 citation

Original Research

Published on 02 Oct 2024

Exploring novel natural compound-based therapies for Duchenne muscular dystrophy management: insights from network pharmacology, QSAR modeling, molecular dynamics, and free energy calculations

in Neuropharmacology

Mohd Saeed
Ashanul Haque
Ambreen Shoaib
Syed Mohd Danish Rizvi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1395014

1,761 views